Cargando…

miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer

MicroRNAs (miRNAs) have been identified as negative posttranscriptional regulators of target genes and are involved directly in the pathological processes of tumors, including drug resistance. However, the exact function of miR-520h in breast cancer remains poorly understood. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Wenwen, Song, Haiyun, Zhao, Qianqian, Dong, Ke, Pu, Qian, Gao, Haidong, Lv, Yanrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391095/ https://www.ncbi.nlm.nih.gov/pubmed/32775453 http://dx.doi.org/10.1155/2020/9512793

Ejemplares similares

The expression change of OTUD3-PTEN signaling axis in glioma cells
por: Liu, Yi-Zhen, et al.
Publicado: (2020)

The Effect of miR-520b on Macrophage Polarization and T Cell Immunity by Targeting PTEN in Breast Cancer
por: Zhu, Qin, et al.
Publicado: (2021)

Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axis
por: Liu, Yang, et al.
Publicado: (2022)

LDL Receptor Pathway Regulation by miR-224 and miR-520d
por: Salerno, Alessandro G., et al.
Publicado: (2020)

SHOC2 is associated with the survival of breast cancer cells and has prognostic value for patients with breast cancer
por: Geng, Wenwen, et al.
Publicado: (2020)

LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling
por: Liu, Xiaofeng, et al.
Publicado: (2022)

Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression
por: Liu, Feng, et al.
Publicado: (2021)

GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
por: Liu, Hao, et al.
Publicado: (2019)

Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR-520a-3p/EGFR axis
por: Xia, Weiyi, et al.
Publicado: (2019)

MiR‐520b restrains cell growth by targeting HDAC4 in lung cancer
por: Jin, Ke, et al.
Publicado: (2018)

Correction to: GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
por: Liu, Hao, et al.
Publicado: (2022)

circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
por: Xie, Hongguo, et al.
Publicado: (2023)

Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014)

MiR-520f acts as a biomarker for the diagnosis of lung cancer
por: Zhou, Yingyan, et al.
Publicado: (2019)

Role of miR-520b in non-small cell lung cancer
por: Zhang, Linlin, et al.
Publicado: (2018)

Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells
por: Pu, Qian, et al.
Publicado: (2020)

miR-382 targeting PTEN-Akt axis promotes liver regeneration
por: Bei, Yihua, et al.
Publicado: (2015)

Circular RNA 0102049 suppresses the progression of osteosarcoma through modulating miR-520g-3p/PLK2 axis
por: Zhang, Xianliao, et al.
Publicado: (2021)

Gene Signatures and Cancer-Immune Phenotypes Based on m(6)A Regulators in Breast Cancer
por: Zhao, Guanghui, et al.
Publicado: (2021)

Loss of OTUD6B Stimulates Angiogenesis and Promotes Diabetic Atherosclerosis
por: Wang, Zhongqun, et al.
Publicado: (2022)

HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2021)

OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21
por: Wang, Zhuolu, et al.
Publicado: (2020)

Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer
por: Sun, Hongwen, et al.
Publicado: (2019)

OTUD7B upregulation predicts a poor response to paclitaxel in patients with triple-negative breast cancer
por: Chiu, Hui-Wen, et al.
Publicado: (2017)

FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
por: He, Wenfeng, et al.
Publicado: (2021)

MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b
por: Tsukerman, Pinchas, et al.
Publicado: (2014)

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)

LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022)

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells
por: Kim, Ki Hyung, et al.
Publicado: (2009)

PVT1/miR-16/CCND1 axis regulates gastric cancer progression
por: Lv, Haidong, et al.
Publicado: (2023)

LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability
por: Li, Peng-Ping, et al.
Publicado: (2021)

miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway
por: Zhang, Hui, et al.
Publicado: (2019)

LncRNA LINC00534 regulates cell proliferation and migration via the miR‐494‐3p/PTEN axis in HTR‐8/SVneo cells
por: Song, Xuejing, et al.
Publicado: (2022)

miR-520c-3p regulates IL-1β-stimulated human chondrocyte apoptosis and cartilage degradation by targeting GAS2
por: Peng, Le, et al.
Publicado: (2021)

MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma
por: Li, Jun, et al.
Publicado: (2020)

Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR-367/PTEN axis
por: Mu, Xin, et al.
Publicado: (2019)

Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR-367/PTEN axis
por: Mu, Xin, et al.
Publicado: (2022)

Salvia miltiorrhiza-derived miRNAs suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA axis
por: Yang, Gao-shan, et al.
Publicado: (2020)

Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR‐520a‐3p/LIMK1 axis
por: Wang, Dongmei, et al.
Publicado: (2020)

Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis
por: Liu, Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11nn82k3gohvl6vr9p5udp3seu